CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...